Published in AIDS Weekly, September 11th, 1995
Writing in a supplemental issue of Clinical Infectious Diseases, Ken Castro noted that new technologies for identifying latent tuberculosis among HIV positive and other immunocompromised persons are also needed.
"Because of the emergence of multidrug-resistant TB and its adverse effect on persons infected with HIV, new drugs and modalities for treating and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.